Europe's Gene Editing Technologies Market, Valued at $370 Million in 2023, is Set to Reach $3.26 Billion by 2032 - Country-Specific Insights for Agriculture & Biomedical Applications Unveiled
30 janv. 2024 07h50 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Gene Editing Technologies Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The Europe gene...
Crispr and Cas Gene Market to Hit $6.47 Billion by 2030: Coherent Market Insights (CMI)
04 déc. 2023 11h09 HE
|
CMI
Burlingame, Dec. 04, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, The global crispr and cas gene market was valued at US$ 1.54 Billion in 2023 and is forecast to reach a value of...
CASGEVY Gets Bahrain approval for treatment, marking it second country in the world
02 déc. 2023 12h59 HE
|
National Health Regulatory Authority
CASGEVY Gets Bahrain approval for treatment, marking it second country in the world
CRISPR Genomic Cure Market Size to Reach $14.80 Billion, Globally, by 2030 at 34.7% CAGR: Coherent Market Insights (CMI)
27 juil. 2023 05h40 HE
|
CMI
Burlingame, July 27, 2023 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, “Crispr Genomic Cure Market, By Disease Type (Genetic Disorders, Cancer, Infectious Diseases,...
CRISPR Technology Market to Reach US$ 7.72 Billion by 2030: Coherent Market Insights
11 juil. 2023 12h18 HE
|
CMI
Burlingame, July 11, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global CRISPR technology market is generated $2.25 billion in 2022, and is anticipated to generate $7.72 billion...
CRISPR Market: 2023 Research Report by Key Players, Global Demand, Industry Size and Share Estimations, Increasing Opportunity Forecast to 2027
12 juin 2023 05h51 HE
|
Absolute Reports Pvt Ltd
Pune, June 12, 2023 (GLOBE NEWSWIRE) -- Global “CRISPR Market” Growth Research 2023-2027: regional developments and industry segments by type and applications. This 103 Pages Report focuses on...
CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies
22 août 2017 07h30 HE
|
CRISPR Therapeutics AG
ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 22, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
CRISPR Therapeutics Announces Exclusive License of Lipid Nanoparticle Technologies Developed at MIT
08 mai 2017 08h00 HE
|
CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
CRISPR Therapeutics to Present at the 16th Annual Needham Healthcare Conference
30 mars 2017 08h00 HE
|
CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., March 30, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology...
CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing
28 mars 2017 08h00 HE
|
CRISPR Therapeutics AG
- Patent to include CRISPR/Cas9 gene editing compositions for use in any non-cellular and cellular setting, including human and other eukaryotic cells BASEL, Switzerland, March 28, 2017 (GLOBE...